In early March 2020, Biotyx representatives and American expert Dr. Daniel McLennan went to Kuala Lumpur, Malaysia to conduct academic exchanges friendly with Dr. Mazeni Alwi and Dr. Koh Ghee Tiong, well-known in the field of cardiac intervention. The topic focuses on the clinical application experience of the IBS Angel™ iron bioabsorbable scaffold independently developed by Biotyx.
(Video: Highlights of academic seminars)
Malaysian Kuala Lumpur National Hospital Station
In the postoperative communication, Dr. Koh Ghee Tiong shared his clinical experience and challenging cases of using IBS Angel™ iron bioabsorbable scaffolds with American experts. The discussion atmosphere was warm, and Dr. Daniel McLennan expressed with excitement that the IBS Angel™ iron bioabsorbable scaffold filled the gap in the world and was a long-awaited children's absorbable scaffold product.
(Dr. Koh Ghee Tiong introduces IBS Angel™ iron bioabsorbable scaffold to Dr. Daniel McLennan from the United States)
Picture: American expert team took a group photo with Dr. Koh Ghee Tiong and Biotyx representatives
Malaysian National Heart Institute Station
The National Heart Institute of Malaysia is the world’s first human clinical trial center for the IBS Angel™ iron bioabsorbable scaffold. As the main clinical investigator of the IBS Angel™ iron bioabsorbable scaffold, Dr. Mazeni Alwi introduced the IBS Angel™ to American experts the results of the clinical trial completed by the iron bioabsorbable scaffold at its center. The current research results show that the immediate success rate of the operation is 100%, and the preliminary results are positive.
(Picture: Dr. Mazeni Alwi introduces the clinical trial results of IBS Angel™ iron bioabsorbable scaffold to American experts.)